AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS GJH BURRIS H SCHELLENS JHM ECKARDT JR PLANTING AST VANDERBURG MEL RODRIGUEZ GI LOOS WJ VANBEURDEN V HUDSON I FIELDS S VONHOFF DD VERWEIJ J
Citation: Gjh. Gerrits et al., ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(5), 1998, pp. 1153-1158
ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS GJH BURRIS H SCHELLENS JHM ECKARDT JR PLANTING AST VANDERBURG MEL RODRIGUEZ GI LOOS WJ VANBEURDEN V HUDSON I FIELDS S VONHOFF DD VERWEIJ J
Citation: Gjh. Gerrits et al., ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(5), 1998, pp. 1153-1158
PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS
Authors: ECKHARDT SG BAKER SD ECKARDT JR BURKE TG WARNER DL KUHN JG RODRIGUEZ G FIELDS S THURMAN A SMITH L ROTHENBERG ML WHITE L WISSEL P KUNKA R DEPEE S LITTLEFIELD D BURRIS HA VONHOFF DD ROWINSKY EK
Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604
PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS
Authors: ECKHARDT SG BAKER SD ECKARDT JR BURKE TG WARNER DL KUHN JG RODRIGUEZ G FIELDS S THURMAN A SMITH L ROTHENBERG ML WHITE L WISSEL P KUNKA R DEPEE S LITTLEFIELD D BURRIS HA VONHOFF DD ROWINSKY EK
Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604
MUTATION DETECTION BY A 2-HYBRID ASSAY
Authors: SCHWARTZ H ALVARES CP WHITE MB FIELDS S
Citation: H. Schwartz et al., MUTATION DETECTION BY A 2-HYBRID ASSAY, Human molecular genetics, 7(6), 1998, pp. 1029-1032
5 DAYS OF ORAL TOPOTECAN (HYCAMTIN(R)), A PHASE-I AND PHARMACOLOGICALSTUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS CJH BURRIS H SCHELLENS JHM PLANTING AST VANDENBURG MEL RODRIGUEZ GI VANBEURDEN V LOOS WJ HUDSON I FIELDS S VERWEIJ J VONHOFF DD
Citation: Cjh. Gerrits et al., 5 DAYS OF ORAL TOPOTECAN (HYCAMTIN(R)), A PHASE-I AND PHARMACOLOGICALSTUDY IN ADULT PATIENTS WITH SOLID TUMORS, European journal of cancer, 34(7), 1998, pp. 1030-1035
NITRATION OF MEMBRANE-PROTEINS IN LUNGS AFTER NORMOXIC ISCHEMIA-REPERFUSION
Authors: HUANG YCT FIELDS S PIANTADOSI CA
Citation: Yct. Huang et al., NITRATION OF MEMBRANE-PROTEINS IN LUNGS AFTER NORMOXIC ISCHEMIA-REPERFUSION, Free radical biology & medicine, 25, 1998, pp. 163-163
UNUSUAL GALLBLADDER FINDINGS IN 2 BROTHERS WITH METACHROMATIC LEUKODYSTROPHY
Authors: SIMANOVSKY N ACKERMAN Z KIDERMAN A FIELDS S
Citation: N. Simanovsky et al., UNUSUAL GALLBLADDER FINDINGS IN 2 BROTHERS WITH METACHROMATIC LEUKODYSTROPHY, Pediatric radiology, 28(9), 1998, pp. 706-708
COMBINATION THERAPY WITH RIBAVIRIN PLUS ALPHA-INTERFERON FOR THE TREATMENT OF CHRONIC HEPATITIS-C IN NAIVE PATIENTS AND USE OF BECK DEPRESSION INVENTORY
Authors: KWO PY FIELDS S BORN L CHALASANI N CHO W CRABB DW CUMMINGS OW IMPERIALE T KRAUSE AK LUMENG L MCGILL JM NESS R CALLON R PINTOZZI R JONES B LANSFORD C PAPPAS SC RUSCHE HF MAIER J ISENBERG M
Citation: Py. Kwo et al., COMBINATION THERAPY WITH RIBAVIRIN PLUS ALPHA-INTERFERON FOR THE TREATMENT OF CHRONIC HEPATITIS-C IN NAIVE PATIENTS AND USE OF BECK DEPRESSION INVENTORY, Hepatology, 28(4), 1998, pp. 478-478
COMBINATION THERAPY WITH RIBAVIRIN PLUS ALPHA-INTERFERON IS BENEFICIAL FOR THE TREATMENT OF CHRONIC HEPATITIS-C IN PATIENTS WHO HAVE FAILEDTREATMENT WITH ALPHA-INTERFERON
Authors: KWO PY POUND DC FIELDS S GLOWINSKI EA BOM L CHALASANI N CHO W CRABB DW CUMMINGS OW IMPERIALE T LUMENG L MCGILL JM NESS R PINTOZZI R JONES B PAPPAS SC RUSCHE HF MAIER J HURWICH D ODEA P
Citation: Py. Kwo et al., COMBINATION THERAPY WITH RIBAVIRIN PLUS ALPHA-INTERFERON IS BENEFICIAL FOR THE TREATMENT OF CHRONIC HEPATITIS-C IN PATIENTS WHO HAVE FAILEDTREATMENT WITH ALPHA-INTERFERON, Hepatology, 28(4), 1998, pp. 854-854
STIMULATION OF P53-MEDIATED TRANSCRIPTIONAL ACTIVATION BY THE P53-BINDING PROTEINS, 53BP1 AND 53BP2
Authors: IWABUCHI K LI B MASSA HF TRASK BJ DATE T FIELDS S
Citation: K. Iwabuchi et al., STIMULATION OF P53-MEDIATED TRANSCRIPTIONAL ACTIVATION BY THE P53-BINDING PROTEINS, 53BP1 AND 53BP2, The Journal of biological chemistry, 273(40), 1998, pp. 26061-26068
AN OPEN-LABEL TRIAL OF RIMANTADINE FOR TREATMENT OF PATIENTS WHO HAVEFAILED OR ARE UNABLE TO TOLERATE INTERFERON THERAPY FOR HEPATITIS-C
Authors: KWO PY FIELDS S BORN L CHALASANI N CHO W CRABB DW CUMMINGS OW IMPERIALE T LUMENG L MCGILL J NESS R
Citation: Py. Kwo et al., AN OPEN-LABEL TRIAL OF RIMANTADINE FOR TREATMENT OF PATIENTS WHO HAVEFAILED OR ARE UNABLE TO TOLERATE INTERFERON THERAPY FOR HEPATITIS-C, Gastroenterology, 114(4), 1998, pp. 343-343
COMBINATION THERAPY WITH RIBOFLAVIN PLUS ALPHA-INTERFERON FOR THE TREATMENT OF CHRONIC HEPATITIS SECONDARY TO HEPATITIS-C VIRUS IN PATIENTSWHO HAVE FAILED TREATMENT WITH ALPHA-INTERFERON
Authors: KWO PY POUND DC FIELDS S GLOWINSKI EA BORN L CHALASANI N CHO W CRABB DW CUMMINGS OW IMPERIALE T LUMENG L MCGILL J NESS R
Citation: Py. Kwo et al., COMBINATION THERAPY WITH RIBOFLAVIN PLUS ALPHA-INTERFERON FOR THE TREATMENT OF CHRONIC HEPATITIS SECONDARY TO HEPATITIS-C VIRUS IN PATIENTSWHO HAVE FAILED TREATMENT WITH ALPHA-INTERFERON, Gastroenterology, 114(4), 1998, pp. 344-344
MAPPING PATHOPHYSIOLOGICAL FEATURES OF BREAST-TUMORS BY MRI AT HIGH-SPATIAL-RESOLUTION
Authors: DEGANI H GUSIS V WEINSTEIN D FIELDS S STRANO S
Citation: H. Degani et al., MAPPING PATHOPHYSIOLOGICAL FEATURES OF BREAST-TUMORS BY MRI AT HIGH-SPATIAL-RESOLUTION, Nature medicine, 3(7), 1997, pp. 780-782
THE FUTURE IS FUNCTION
Authors: FIELDS S
Citation: S. Fields, THE FUTURE IS FUNCTION, Nature genetics, 15(4), 1997, pp. 325-327
THE COMPLETE SET OF PREDICTED GENES FROM SACCHAROMYCES-CEREVISIAE IN A READILY USABLE FORM
Authors: HUDSON JR DAWSON EP RUSHING KL JACKSON CH LOCKSHON D CONOVER D LANCIAULT C HARRIS JR SIMMONS SJ ROTHSTEIN R FIELDS S
Citation: Jr. Hudson et al., THE COMPLETE SET OF PREDICTED GENES FROM SACCHAROMYCES-CEREVISIAE IN A READILY USABLE FORM, PCR methods and applications, 7(12), 1997, pp. 1169-1173
POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC)
Authors: ECKARDT J DEPIERRE A ARDIZZONI A VONPAWEL J FIELDS S
Citation: J. Eckardt et al., POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 33, 1997, pp. 1041-1041
A COMPARISON OF CLINICAL PHARMACODYNAMICS OF DIFFERENT ADMINISTRATIONSCHEDULES OF ORAL TOPOTECAN (TPT, HYCAMTIN(R))
Authors: GERRITS C SCHELLENS J BURRIS H PLANTING A VANDERBURG M VANBEURDEN V LOOS W HUDSON I FIELDS S VONHOFF D VERWEIJ J
Citation: C. Gerrits et al., A COMPARISON OF CLINICAL PHARMACODYNAMICS OF DIFFERENT ADMINISTRATIONSCHEDULES OF ORAL TOPOTECAN (TPT, HYCAMTIN(R)), European journal of cancer, 33, 1997, pp. 1105-1105
TRANSCRIPTIONAL ACTIVATION UPON PHEROMONE STIMULATION MEDIATED BY A SMALL DOMAIN OF SACCHAROMYCES-CEREVISIAE STE12P
Authors: PI HW CHIEN CT FIELDS S
Citation: Hw. Pi et al., TRANSCRIPTIONAL ACTIVATION UPON PHEROMONE STIMULATION MEDIATED BY A SMALL DOMAIN OF SACCHAROMYCES-CEREVISIAE STE12P, Molecular and cellular biology, 17(11), 1997, pp. 6410-6418
EXPOSING OURSELVES TO ART
Authors: FIELDS S
Citation: S. Fields, EXPOSING OURSELVES TO ART, Environmental health perspectives, 105(3), 1997, pp. 284-289
A CONSERVED RNA-BINDING PROTEIN THAT REGULATES SEXUAL FATES IN THE C-ELEGANS HERMAPHRODITE GERM-LINE
Authors: ZHANG BL GALLEGOS M PUOTI A DURKIN E FIELDS S KIMBLE J WICKENS MP
Citation: Bl. Zhang et al., A CONSERVED RNA-BINDING PROTEIN THAT REGULATES SEXUAL FATES IN THE C-ELEGANS HERMAPHRODITE GERM-LINE, Nature, 390(6659), 1997, pp. 477-484
ADRENOMEDULLIN EXPRESSION IN AMNIOTIC MEMBRANES - POSSIBLE PATHOGENETIC ROLE FOR ADRENOMEDULLIN IN AMNIOTIC-FLUID EMBOLISM
Authors: HAMILTON R FIELDS S LASTRAPES D LIVINGSTON S HOLMQUIST S MUROCACHO CA
Citation: R. Hamilton et al., ADRENOMEDULLIN EXPRESSION IN AMNIOTIC MEMBRANES - POSSIBLE PATHOGENETIC ROLE FOR ADRENOMEDULLIN IN AMNIOTIC-FLUID EMBOLISM, Laboratory investigation, 76(1), 1997, pp. 585-585
THE METAPHYSICS OF SYMBOL IN THOMISM - 'AETERNI PATRIS' TO RAHNER
Authors: FIELDS S
Citation: S. Fields, THE METAPHYSICS OF SYMBOL IN THOMISM - 'AETERNI PATRIS' TO RAHNER, International philosophical quarterly, 37(3), 1997, pp. 277-290
QUALITY-CONTROL OF SPIROMETRY TESTING IN THE REGISTRY FOR PATIENTS WITH SEVERE ALPHA(1)-ANTITRYPSIN DEFICIENCY
Authors: STOLLER JK BUIST AS BURROWS B CRYSTAL RG FALLAT RJ MCCARTHY K SCHLUCHTER MD SOSKEL NT ZHANG R BENGALI Z DESHLER J VREIM CE ROTHGEB A WU M SNIDER GL DETRE K REYNOLDS HY TOCKMAN MS WITTES J COHEN A GADEK JE ROUSELL RH SCHWARTZ RS TURINO GM BRANTLY ML HURD S WILLIAMS GW AJAMOUGHLI R BECK GJ CONNELLY RP DOBISH B GOORMASTIC M LEATHERMAN J MCMAHAN J MIDCALF V MOORE B SARTORI P SHERER SG SWINDERMAN D TUASON M WIEDEMANN HP DOBISH ME PETTY TL HILDESHEIM J RUNDQUIST B SANDHAUS RA BELL CW BEREND J BURRY CA IRVINE K KRANTZ D LEWIS S RAVIKRISHNAN KP BEGLE R CAMERON B COTTON S SEIDMAN J SHERMAN S TRUE M WEINBERGER S ARMSTRONG K JOHNSTON R ROSENBERG M LAROCK JB MORIYAMA L WILLARD K ARROLIGA AC MEEKER DP CASSIDY E GOLISH JA HUTCHINS L LASKOWSKI D MEHTA A PAGLIACCIO L PILLAR R RHODES G SCOTT J SOENTJEN L RYAN WJ JOHNSON K LOFTIN JP KOTCH A CLARK T EPSTEIN PE DELBUONO P SANDBLOM RE COLLAR L CURTIS M DEMAINE JB MELSON B EICHENHORN MS BEAUCHAMP R HUPFER S LUKASZEK C MACKEWICH R WILSON C BREITE WM MCMAHAN JP DEATLEY R MYLET D WILLIAMS T WEBBJOHNSON D CORBETT J JUDD L MCMANUS D PIERCE J KROWKA MJ AWAN Z FEHRENKAMP R MADDEN M SCHULTZ K WHEATLEY N PRAKASH UBS NESLER D SCOTT L SCANLON P STAATS B VIGGIANO R STRANGE C BAUMANN M BURNS B JUDSON M OSER R YOUMANS M KILLIAN DN DEMICCO W GOLDEN L HESS SA HITCHCOCK R RAYMOND G MOSS J BARNES P CZERSKI D HEALY J JOLLEY C MCELVANEY NG ROBINSON W TAYLOR G METH BM HOLDEN D ASHBURN RW CROWDER G DOLENSKY R HAMILTON C JONES S FORRESTER J SARLIN RF SEN RP SHELTON B SCHULER B TYLER M WALSH TE ZARATE J WEWERS M DRAKE J JAMES B SWANK B BARKER AF DSILVA R OVESON L WINTHER L SHEEHAN WC AISENBERG RM CHADBOURNE L DEMERS P LITTLE P MUCCIARDI N OLIVERAWILLIAMS D SHEEHAN A EDEN E KLUGH T PARMAR SI MIDDLETON ML MONTAGUE D KLINK M BEELER EP BOYER B CLINE M GORDON D CROSS CE BOOTH JA CHAN A FEKETE R KEMNITZ H VOLZ W TIERNEY DF EZELL L HAUGH J SHAPIRO B CLAUSEN JL BORDERS J DENT C FONZI C FORD R KING SJ LOPEZ C WILSON J BUCHMAYER J ANDERSON M BITTERMAN P DOSLAND B EDIN C HARMON K HERTZ M KRAUSE S LINDQUIST P LOVENBELL M PLOOSTER K RENNARD SI CHENEY R CIRIAN D DIAMOND J EPPERSON K FOGLEMAN R HOUCHINS J JONES K MCGRANAGHAN S PIGNOTTI T PURSEL T ROBBINS RA DONOHUE JF DAVIS L HOHNEKER KW HORNADAY B MASCRELLA J SOBOL L TURPIN S HYDE RW LYNCH R SPOHN B GRISHAM C JONES C PATRICK T STOCKS JM BLEVINS WJ FIELDS S HINOJOSA J WALDROP D WILSON E KANNER RE CAMPBELL EJ BEHNKE J POPE K THELANDER C GROSS N KING F WATERS I MACNEILL L NELSON P HOROWITZ M FRANKLIN B JENKERSON M PIERCE JA SILVERMAN E STORY N WADE M WILSON P
Citation: Jk. Stoller et al., QUALITY-CONTROL OF SPIROMETRY TESTING IN THE REGISTRY FOR PATIENTS WITH SEVERE ALPHA(1)-ANTITRYPSIN DEFICIENCY, Chest, 111(4), 1997, pp. 899-909
A PROTEIN LINKAGE MAP OF ESCHERICHIA-COLI BACTERIOPHAGE-T7
Authors: BARTEL PL ROECKLEIN JA SENGUPTA D FIELDS S
Citation: Pl. Bartel et al., A PROTEIN LINKAGE MAP OF ESCHERICHIA-COLI BACTERIOPHAGE-T7, Nature genetics, 12(1), 1996, pp. 72-77
Risultati: 1-25 | 26-50 | 51-63